|
3 Companies |
|
0 Products |
|
0 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
10 News |
|
- Isentress (raltegravir) / Merck (MSD)
Trial primary completion date: Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy (clinicaltrials.gov) - Jan 17, 2017
P=N/A, N=25, Completed, Sponsor: University of California, Davis
Trial primary completion date: Dec 2010 --> Sep 2010
- Trial completion, Enrollment change, Trial primary completion date: Pregnancy Chances in Classic Galactosemia (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=85, Completed, Sponsor: Maastricht University Medical Center
Trial primary completion date: Dec 2010 --> Sep 2010 Recruiting --> Completed | N=150 --> 85 | Trial primary completion date: Dec 2015 --> Sep 2016
- Trial completion: Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=30, Completed, Sponsor: Clara Lehmann
Recruiting --> Completed | N=150 --> 85 | Trial primary completion date: Dec 2015 --> Sep 2016 Recruiting --> Completed
- Trial completion: VIRECT: Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men (clinicaltrials.gov) - Nov 2, 2015
P=N/A, N=30, Completed, Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Recruiting --> Completed Recruiting --> Completed
- New trial: VIRECT: Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men (clinicaltrials.gov) - Aug 18, 2015
P=N/A, N=30, Recruiting, Sponsor: Centre Hospitalier Universitaire de Saint Etienne
- Trial completion: The Early History of Universal Screening for Metabolic Disorders (clinicaltrials.gov) - Aug 21, 2014
P=N/A, N=10, Completed, Sponsor: University of Miami
Recruiting --> Completed Active, not recruiting --> Completed
- Clinical: Glycosylation in Patients With Galactosaemia (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=26, Completed, Sponsor: Children's University Hospital, Ireland
- Selzentry (maraviroc) / ViiV Healthcare
Trial completion: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy (clinicaltrials.gov) - Sep 14, 2013
P4, N=44, Completed, Sponsor: University of California, Davis
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Clinical: Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients (clinicaltrials.gov) - Sep 3, 2012
P=N/A, N=30, Recruiting, Sponsor: Clara Lehmann